ArticleJournal of medical cases2026
Triple-Negative Inflammatory Metaplastic Breast Cancer Presenting as a Non-Mass Lesion.
Article in Journal of medical cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory breast cancer is exceedingly rare, especially when the pathology involves invasive carcinoma alongside metaplastic carcinoma. This disease constitutes a diagnostic and therapeutic challenge, largely due to a scarcity of documented cases in the literature. We reported a case of a female patient who presented with axillary lymphadenopathy and diffuse swelling of a single breast without a solid mass. During hospitalization, she underwent various diagnostic procedures, including lymph node fine-needle aspiration, axillary lymph node biopsy, pleural effusion puncture, magnetic resonance imaging (MRI), and positron emission tomography-computed tomography (PET-CT). Despite these extensive investigations, a definitive diagnosis could not be established. The pathological nature was ultimately clarified through a core needle biopsy of the breast lesion, which subsequently guided the clinical treatment. This case highlights the complexity and challenge of diagnosing metaplastic carcinoma within inflammatory breast cancer, as well as the necessity of performing a core needle biopsy on inflammatory lesions when no solid mass is present.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.